Bridgefront Capital’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,781
| Closed | -$53.6K | – | 381 |
|
|
2023
Q2 | $53.6K | Sell |
10,781
-28,746
| -73% | -$143K | 0.03% | 427 |
|
|
2023
Q1 | $195K | Buy |
+39,527
| New | +$195K | 0.12% | 348 |
|
|
2022
Q4 | – | Sell |
-20,512
| Closed | -$222K | – | 356 |
|
|
2022
Q3 | $222K | Buy |
+20,512
| New | +$222K | 0.23% | 203 |
|
|
2021
Q1 | – | Sell |
-14,670
| Closed | -$370K | – | 654 |
|
|
2020
Q4 | $370K | Buy |
+14,670
| New | +$370K | 0.13% | 299 |
|